DEVELOPMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPLICATIONS

Recombinant human serum albumin (OsrHSA) has emerged as a big innovation in the sector of biopharmaceuticals, supplying promising advancements across several clinical and industrial programs. With its structural similarity to naturally derived human serum albumin, OsrHSA supplies a safer, additional reliable option for therapeutic use, specifically